Becton Dickinson Operating Expenses 2010-2024 | BDX
Becton Dickinson annual/quarterly operating expenses history and growth rate from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
- Becton Dickinson operating expenses for the quarter ending June 30, 2024 were $4.388B, a 1.32% increase year-over-year.
- Becton Dickinson operating expenses for the twelve months ending June 30, 2024 were $17.703B, a 5.39% increase year-over-year.
- Becton Dickinson annual operating expenses for 2023 were $17.261B, a 4.06% increase from 2022.
- Becton Dickinson annual operating expenses for 2022 were $16.587B, a 1.74% decline from 2021.
- Becton Dickinson annual operating expenses for 2021 were $16.88B, a 11.33% increase from 2020.
Becton Dickinson Annual Operating Expenses
(Millions of US $) |
| 2023 |
$17,261 |
| 2022 |
$16,587 |
| 2021 |
$16,880 |
| 2020 |
$15,162 |
| 2019 |
$15,530 |
| 2018 |
$14,474 |
| 2017 |
$10,571 |
| 2016 |
$11,053 |
| 2015 |
$9,208 |
| 2014 |
$6,840 |
| 2013 |
$6,799 |
| 2012 |
$6,150 |
| 2011 |
$5,919 |
| 2010 |
$5,542 |
| 2009 |
$5,397 |
Becton Dickinson Quarterly Operating Expenses
(Millions of US $) |
| 2024-06-30 |
$4,388 |
| 2024-03-31 |
$4,311 |
| 2023-12-31 |
$4,268 |
| 2023-09-30 |
$4,736 |
| 2023-06-30 |
$4,331 |
| 2023-03-31 |
$4,194 |
| 2022-12-31 |
$4,000 |
| 2022-09-30 |
$4,272 |
| 2022-06-30 |
$4,104 |
| 2022-03-31 |
$4,184 |
| 2021-12-31 |
$4,027 |
| 2021-09-30 |
$4,218 |
| 2021-06-30 |
$4,115 |
| 2021-03-31 |
$4,474 |
| 2020-12-31 |
$4,073 |
| 2020-09-30 |
$4,058 |
| 2020-06-30 |
$3,496 |
| 2020-03-31 |
$3,884 |
| 2019-12-31 |
$3,724 |
| 2019-09-30 |
$4,473 |
| 2019-06-30 |
$3,724 |
| 2019-03-31 |
$4,059 |
| 2018-12-31 |
$3,274 |
| 2018-09-30 |
$3,827 |
| 2018-06-30 |
$3,767 |
| 2018-03-31 |
$4,035 |
| 2017-12-31 |
$2,845 |
| 2017-09-30 |
$2,676 |
| 2017-06-30 |
$3,259 |
| 2017-03-31 |
$2,524 |
| 2016-12-31 |
$2,112 |
| 2016-09-30 |
$3,135 |
| 2016-06-30 |
$2,682 |
| 2016-03-31 |
$2,602 |
| 2015-12-31 |
$2,634 |
| 2015-09-30 |
$2,765 |
| 2015-06-30 |
$2,983 |
| 2015-03-31 |
$1,758 |
| 2014-12-31 |
$1,702 |
| 2014-09-30 |
$1,801 |
| 2014-06-30 |
$1,711 |
| 2014-03-31 |
$1,691 |
| 2013-12-31 |
$1,637 |
| 2013-09-30 |
$2,024 |
| 2013-06-30 |
$1,648 |
| 2013-03-31 |
$1,619 |
| 2012-12-31 |
$1,508 |
| 2012-09-30 |
$1,578 |
| 2012-06-30 |
$1,532 |
| 2012-03-31 |
$1,546 |
| 2011-12-31 |
$1,495 |
| 2011-09-30 |
$1,504 |
| 2011-06-30 |
$1,505 |
| 2011-03-31 |
$1,482 |
| 2010-12-31 |
$1,429 |
| 2010-09-30 |
$1,309 |
| 2010-06-30 |
$1,408 |
| 2010-03-31 |
$1,386 |
| 2009-12-31 |
$1,439 |
| 2009-09-30 |
$1,345 |
| 2009-06-30 |
$1,388 |
| 2009-03-31 |
$1,364 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$67.812B |
$20.178B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
